CYNTHIA VEAL: Open Payments
NPI 1508005331 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 14 payments from 8 companies in 2025. Trend: 2023 $1,102 · 2024 $300 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $78 |
| 180 Medical, Inc. | 3 | $65 |
| PFIZER INC. | 2 | $50 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $46 |
| ConvaTec Inc. | 1 | $42 |
| Astellas Pharma US Inc | 1 | $33 |
| ABBVIE INC. | 1 | $24 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $17 |
Products named: XTANDI, ERLEADA, PYLARIFY, GENTLECATH, BOTOX, Aptra.
Industry payments across NV — which companies pay providers there.
